等待開盤 09-17 09:30:00 美东时间
+1.160
+3.25%
Parabilis Medicines announced the appointment of Craig L. Tendler, M.D., to its Board of Directors. Dr. Tendler, a seasoned oncology expert with over 30 years of experience at Johnson & Johnson, will also continue his role as a scientific advisor. His extensive background in clinical development and regulatory approvals is expected to significantly benefit Parabilis as it advances its lead drug, zolucatetide, and expands its pipeline of innovativ...
08-25 11:00
Parabilis Medicines (NASDAQ:PBLS) reported quarterly losses of $(2.32) per share which missed the analyst consensus estimate of $(0.08) by 2800 percent. This is a 89.59 percent increase over losses of $(22.28) per share from the same period last year. The company reported quarterly sales of $148.000...
08-13 19:29
今年美国首次公开募股(IPO)市场的最大赢家并非人工智能(AI)企业,而是生物科技板块。受行业基本面改善、大型药企并购活跃以及资本持续流入推动,生物科技IPO表...
07-21 23:23
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
07-18 18:30
今日重点评级关注:Roth Capital:维持Nuvectis Pharma"买入"评级,目标价从20美元升至33美元;摩根士丹利:维持GXO Logistics"超配"评级,目标价从75美元升至78美元
07-07 11:34
B of A Securities analyst Tazeen Ahmad initiates coverage on Parabilis Medicines (NASDAQ:PBLS) with a Buy rating and announces Price Target of $45.
07-06 18:29
生物制药股NUVL涨超35%,获葛兰素史克高额溢价收购;支付公司Payoneer涨超33%,获加拿大支付公司Nuvei收购;超微电脑跌超26%,70亿美元的股权融资引市场忧虑>>
06-13 09:46
临床阶段生物制药公司Parabilis Medicines本周完成了有史以来规模最大的风投支持生物科技首次公开募股,筹资约6.7亿美元,超出此前由Kail...
06-11 20:49
新股PBLS大涨58%,此前获10倍超购募资7.45亿美元;FAC大涨37%,近日完成SPAC合并登陆纳斯达克;凯西通用零售涨逾20%,Q4业绩超预期并大幅上调股息>>
06-11 16:35